Category: clinical study retractions

Not your data: Nursing paper retracted for misuse of findings

nurse education todayWe’re all for research on improving communication and collaboration among colleagues. But we trust that the experts know what they’re doing. You can see where this is going.

The journal Nurse Education Today has retracted a 2012 article, “Interprofessional learning in acute care: Developing a theoretical framework,” by a UK scholar because, how shall we put it, he might need a few lessons in interprofessionalism.

The retraction notice explains it neatly: Continue reading Not your data: Nursing paper retracted for misuse of findings

“Technical but fundamental errors” lead to retraction of brain tumor paper

neuro-oncologyThe journal Neuro-Oncology has retracted a 2011 paper by a group of researchers in Japan who had purported to find a genetic mechanism for how fluorescence can be used to diagnose certain brain tumors.

The paper, “Enhanced expression of coproporphyrinogen oxidase in malignant brain tumors: CPOX expression and 5-ALA–induced fluorescence,” reported measurements using quantitative real-time (qRT)-PCR.

As the retraction notice explains: Continue reading “Technical but fundamental errors” lead to retraction of brain tumor paper

BioMed Central retracts study it published twice while acquiring journal

jdmdYesterday, we wrote about the retraction of a paper that ended up published despite the fact that peer reviewers had recommended rejecting it. Today, we have the (short) tale of a paper retracted because the publisher posted it a second time while they were buying acquiring the journal where it appeared.

Here’s the notice for “The association between depression, socio-economic factors and dietary intake in mothers having primary school children living in Rey, South of Tehran, Iran,” published in the Journal of Diabetes & Metabolic Diseases: Continue reading BioMed Central retracts study it published twice while acquiring journal

Nanotech researcher SK Sahoo notches fifth retraction

acta biomaterialiaNanotech researcher SK Sahoo, whom as we reported in February lost four papers from Acta Biomaterialia for what the journal called “highly unethical practices,” has actually retracted five papers from that journal.

According to a notice for “Enhanced cellular uptake and in vivo pharmacokinetics of rapamycin loaded cubic phase nanoparticles for cancer therapy” that appears in the June issue along with the other four: Continue reading Nanotech researcher SK Sahoo notches fifth retraction

Madoff retracts scientific paper

dcrectNo, not that Madoff.

We’re talking about Robert Madoff, editor of Diseases of the Colon & Rectum. His journal is pulling a 2012 paper by a group of authors in Spain who seem to have been unable to back up their findings when they were found to contain errors.

The article, “Perianal versus endoanal application of glyceryl trinitrate 0.4% ointment in the treatment of chronic anal fissure: results of a randomized controlled trial. Is this the solution to the headaches?” looked at what evidently is a significant side effect of nitroglycerin treatment for anal fissures: headaches. According to the abstract:

Continue reading Madoff retracts scientific paper

Failure to reproduce experiments, errors lead to retraction of pancreatic cancer paper

lab investThe authors of a paper in Laboratory Investigation have retracted it after they were unable to “reproduce key experiments,” and discovered “several minor errors.”

Here’s the retraction notice for “Slug enhances invasion ability of pancreatic cancer cells through upregulation of matrix metalloproteinase-9 and actin cytoskeleton remodeling,” by Liqun Wu and colleagues of The Affiliated Hospital of Medical College, QingDao University, in China’s Shan Dong Province: Continue reading Failure to reproduce experiments, errors lead to retraction of pancreatic cancer paper

Paper by Bristol-Myers Squibb researchers retracted for “unsolved legal reasons”

applied micro biotechA group of researchers at Bristol-Myers Squibb has had a paper retracted for reasons we can’t quite figure out.

All the notice for “Simultaneous expression of antibody light and heavy chains in Pichia pastoris: improving retransformation outcome by linearizing vector at a different site,” published in Applied Microbiology and Biotechnology, says is: Continue reading Paper by Bristol-Myers Squibb researchers retracted for “unsolved legal reasons”

Retraction for image issues forces correction of herbal remedies editorial

jmm mayBack in March, we wrote about the case of Chinese researchers who pulled their 2011 paper in the Journal of Molecular Medicine on ginseng’s potential as a heart remedy because a couple of their images were suspect (duplicated was the word they’d used).

Turns out the journal suffered some collateral damage. JMM also has corrected a “Clinical Implications” article by a group of Canadian researchers about the defunct ginseng paper.

The article, “Use of ginseng to reduce post-myocardial adverse myocardial remodeling: applying scientific principles to the use of herbal therapies,”  appeared in the same issue as the original, but for some reason the correction notice appeared online only last week.

It states: Continue reading Retraction for image issues forces correction of herbal remedies editorial

Two Expressions of Concern in Blood for MD Anderson’s Aggarwal, who has threatened to sue Retraction Watch

aggarwalBharat Aggarwal, the MD Anderson researcher who has threatened to sue us while under investigation by his institution for alleged misconduct, now has two Expressions of Concern in addition to two corrections and two unexplained withdrawals.

Both of the papers were published in Blood. The Expression of Concern for “Gambogic acid, a novel ligand for transferrin receptor, potentiates TNF-induced apoptosis through modulation of the nuclear factor-κB signaling pathway,” reads: Continue reading Two Expressions of Concern in Blood for MD Anderson’s Aggarwal, who has threatened to sue Retraction Watch

Heart pulls sodium meta-analysis over duplicated, and now missing, data

heart cover may13The journal Heart has retracted a 2012 meta-analysis after learning that two of the six studies included in the review contained duplicated data.  Those studies, it so happens, were conducted by one of the co-authors.

The article, “Low sodium versus normal sodium diets in systolic heart failure: systematic review and meta-analysis,” came from an eclectic group of authors from the United States, Canada and Italy (the first author is listed as being at a Wegmans pharmacy in Ithaca, N.Y.). The paper, published online in August 2012, purported to find that: Continue reading Heart pulls sodium meta-analysis over duplicated, and now missing, data